Skip to main content
SpringerLink
Log in

Hepatic Steatosis in Hepatitis C Virus Genotype 3 Infection: Does It Correlate with Body Mass Index, Fibrosis, and HCV Risk Factors?

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Hepatic steatosis is a recognized feature of hepatitis C viral infection, particularly in genotype 3. The demographics and the associations contributing to moderate to severe steatosis in genotype 3 are not very well studied. The aim of this study is to determine the demographics and association of steatosis with fibrosis, obesity, diabetes, lipid levels, and risk factors among patients with hepatitis C virus (HCV) genotype 3. Two hundred ninety-three consecutive HCV patients (genotype 1, n = 218; genotype 2, n = 43; genotype 3, n = 32) at our institution were studied retrospectively. Demographic information such as height, weight, genotype, risk factors, serum cholesterol and triglyceride, and liver biopsy was collected. Steatosis was graded using the Brunt classification. HCV genotype 3-infected patients were younger (P < 0.04) and had lower serum cholesterol levels (P < 0.02) compared to nongenotype 3 patients. Moderate to severe steatosis was more prevalent in HCV genotype 3 patients (P < 0.001) with intravenous drug abuse as a risk factor (P = 0.04). Genotype 3 was the independent predictor of steatosis in all patients. There was no statistical association between grade of steatosis and body mass index, fibrosis, necroinflammation, or hyperlipidemia when only HCV genotype 3 patients were included in the multivariate logistic model. Hepatic steatosis is a feature of genotype 3. Patients with HCV genotype 3 are younger and have lower serum cholesterol levels. Genotype 3 is the independent predictor for steatosis in HCV patients. HCV genotype 3 patients with moderate to severe steatosis are more likely to have intravenous drug use as a risk factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Alter MJ, Kruszon-Moran D, Nainan OV, et al.: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341(8):556–562, 1999

    Google Scholar 

  2. Wong VS, Wight DG, Palmer CR, Alexander GJ: Fibrosis and other histological features in chronic hepatitis C virus infection: a statistical model. J Clin Pathol 49(6):465–469, 1996

    Google Scholar 

  3. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM: The pathology of hepatitis C. Hepatology 15(4):567–571, 1992

    Google Scholar 

  4. Bach N, Thung SN, Schaffner F: The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology 15(4):572–577, 1992

    Google Scholar 

  5. Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL: Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 36(3):729–736, 2002

    Google Scholar 

  6. Mihm S, Fayyazi A, Hartmann H, Ramadori G: Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 25(3):735–739, 1997

    Google Scholar 

  7. Rubbia-Brandt L, Leandro G, Spahr L, et al.: Liver steatosis in chronic hepatitis C: a morphological sign suggesting infection with HCV genotype 3. Histopathology 39(2):119–124, 2001

    Google Scholar 

  8. Serfaty L, Andreani T, Giral P, Carbonell N, Chazouilleres O, Poupon R: Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C. J Hepatol 34(3):428–434, 2001

    Google Scholar 

  9. Adinolfi LE, Utili R, Andreana A, et al.: Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients. Eur J Gastroenterol Hepatol 12(3):299–304, 2000

    Google Scholar 

  10. Westin J, Nordlinder H, Lagging M, Norkrans G, Wejstal R: Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol 37(6):837–842, 2002.

    Google Scholar 

  11. Brunt EM: Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 31(1):241–246, 2000

    Google Scholar 

  12. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94(9):2467–2474, 1999

    Google Scholar 

  13. Rubbia-Brandt L, Quadri R, Abid K, et al.: Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 33(1):106–115, 2000

    Google Scholar 

  14. Hofer H, Bankl HC, Wrba F, et al.: Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a. Am J Gastroenterol 97(11):2880–2885, 2002

    Google Scholar 

  15. Hourigan LF, Macdonald GA, Purdie D, et al.: Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29(4):1215–1219, 1999

    Google Scholar 

  16. Moriya K, Yotsuyanagi H, Shintani Y, et al.: Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 78(Pt 7):1527–1531, 1997

    Google Scholar 

  17. Adinolfi LE, Utili R, Andreana A, et al.: Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. Dig Dis Sci 46(8):1677–1683, 2001

    Google Scholar 

  18. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G: Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33(6):1358–1364, 2001

    Google Scholar 

  19. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB: Host-and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 29(2):198–206, 1998

    Google Scholar 

  20. Ong JP, Younossi ZM, Speer C, Olano A, Gramlich T, Boparai N: Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. Liver 21(4):266–71, 2001

    Google Scholar 

  21. Lagging LM, Westin J, Svensson E, et al.: Progression of fibrosis in untreated patients with hepatitis C virus infection. Liver 22(2):136–144, 2002

    Google Scholar 

  22. Kumar D, Farrell GC, Fung C, George J: Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response. Hepatology 36(5):1266–1272, 2002

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Transplant Medicine, Mayo Clinic, Scottsdale, Arizona, USA

    Pratima Sharma, Vijayan Balan, Hector Rodriguez-Luna, Joan Schwartz, Edwyn Harrison, Monte Anderson, Thomas Byrne, Hugo E. Vargas, David D. Douglas & Jorge Rakela

  2. Department of Biostatistics, Mayo Clinic, Scottsdale, Arizona, USA

    Jose Hernandez & Marianne Rosati

  3. Department of Pathology, Mayo Clinic, Scottsdale, Arizona, USA

    James Williams

Authors
  1. Pratima Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vijayan Balan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jose Hernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marianne Rosati
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. James Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hector Rodriguez-Luna
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joan Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Edwyn Harrison
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Monte Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Thomas Byrne
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hugo E. Vargas
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. David D. Douglas
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Jorge Rakela
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharma, P., Balan, V., Hernandez, J. et al. Hepatic Steatosis in Hepatitis C Virus Genotype 3 Infection: Does It Correlate with Body Mass Index, Fibrosis, and HCV Risk Factors?. Dig Dis Sci 49, 25–29 (2004). https://doi.org/10.1023/B:DDAS.0000011597.92851.56

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:DDAS.0000011597.92851.56

Search

Navigation